Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 225

Similar articles for PubMed (Select 21183501)

1.

Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditis.

Van Linthout S, Savvatis K, Miteva K, Peng J, Ringe J, Warstat K, Schmidt-Lucke C, Sittinger M, Schultheiss HP, Tschöpe C.

Eur Heart J. 2011 Sep;32(17):2168-78. doi: 10.1093/eurheartj/ehq467. Epub 2010 Dec 22. Erratum in: Eur Heart J. 2013 Feb;34(8):604.

2.

Human cardiac-derived adherent proliferating cells reduce murine acute Coxsackievirus B3-induced myocarditis.

Miteva K, Haag M, Peng J, Savvatis K, Becher PM, Seifert M, Warstat K, Westermann D, Ringe J, Sittinger M, Schultheiss HP, Tschöpe C, Van Linthout S.

PLoS One. 2011;6(12):e28513. doi: 10.1371/journal.pone.0028513. Epub 2011 Dec 9.

3.

Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo.

Riad A, Westermann D, Escher F, Becher PM, Savvatis K, Lettau O, Heimesaat MM, Bereswill S, Volk HD, Schultheiss HP, Tschöpe C.

Am J Physiol Heart Circ Physiol. 2010 Jun;298(6):H2024-31. doi: 10.1152/ajpheart.01188.2009. Epub 2010 Mar 12.

4.

Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.

Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS.

Infect Immun. 1983 Feb;39(2):851-64.

5.

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

Weithauser A, Bobbert P, Antoniak S, Böhm A, Rauch BH, Klingel K, Savvatis K, Kroemer HK, Tschope C, Stroux A, Zeichhardt H, Poller W, Mackman N, Schultheiss HP, Rauch U.

J Am Coll Cardiol. 2013 Nov 5;62(19):1737-45. doi: 10.1016/j.jacc.2013.05.076. Epub 2013 Jul 17.

6.

IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.

Fairweather D, Frisancho-Kiss S, Yusung SA, Barrett MA, Davis SE, Steele RA, Gatewood SJ, Rose NR.

J Immunol. 2005 Jan 1;174(1):261-9.

7.

Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.

Jenke A, Holzhauser L, Löbel M, Savvatis K, Wilk S, Weithäuser A, Pinkert S, Tschöpe C, Klingel K, Poller W, Scheibenbogen C, Schultheiss HP, Skurk C.

Basic Res Cardiol. 2014 May;109(3):408. doi: 10.1007/s00395-014-0408-y. Epub 2014 Apr 2.

PMID:
24691762
8.

CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.

Yuan J, Liu Z, Lim T, Zhang H, He J, Walker E, Shier C, Wang Y, Su Y, Sall A, McManus B, Yang D.

Circ Res. 2009 Mar 13;104(5):628-38. doi: 10.1161/CIRCRESAHA.108.192179. Epub 2009 Jan 22.

9.

α-Galactosylceramide protects mice from lethal Coxsackievirus B3 infection and subsequent myocarditis.

Wu CY, Feng Y, Qian GC, Wu JH, Luo J, Wang Y, Chen GJ, Guo XK, Wang ZJ.

Clin Exp Immunol. 2010 Oct;162(1):178-87. doi: 10.1111/j.1365-2249.2010.04233.x. Epub 2010 Aug 19.

10.
11.

Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.

Savvatis K, van Linthout S, Miteva K, Pappritz K, Westermann D, Schefold JC, Fusch G, Weithäuser A, Rauch U, Becher PM, Klingel K, Ringe J, Kurtz A, Schultheiss HP, Tschöpe C.

PLoS One. 2012;7(7):e41047. doi: 10.1371/journal.pone.0041047. Epub 2012 Jul 17.

12.

CTLA4-Ig relieves inflammation in murine models of coxsackievirus B3-induced myocarditis.

Han B, Jiang H, Liu Z, Zhang Y, Zhao L, Lu K, Xi J.

Can J Cardiol. 2012 Mar-Apr;28(2):239-44. doi: 10.1016/j.cjca.2011.11.014. Epub 2012 Feb 14.

PMID:
22336520
13.

The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis.

Henke A, Huber S, Stelzner A, Whitton JL.

J Virol. 1995 Nov;69(11):6720-8.

14.

Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3.

Seko Y, Kayagaki N, Seino K, Yagita H, Okumura K, Nagai R.

J Am Coll Cardiol. 2002 Apr 17;39(8):1399-403.

PMID:
11955862
15.

Effects of in vivo administration of anti-B7-1/B7-2 monoclonal antibodies on murine acute myocarditis caused by coxsackievirus B3.

Seko Y, Takahashi N, Azuma M, Yagita H, Okumura K, Yazaki Y.

Circ Res. 1998 Mar 23;82(5):613-8.

17.

Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.

Zhang Y, Zhu H, Huang C, Cui X, Gao Y, Huang Y, Gong W, Zhao Y, Guo S.

J Cardiovasc Pharmacol. 2006 Feb;47(2):190-5.

PMID:
16495755
18.

Expression of intercellular adhesion molecule-1 in murine hearts with acute myocarditis caused by coxsackievirus B3.

Seko Y, Matsuda H, Kato K, Hashimoto Y, Yagita H, Okumura K, Yazaki Y.

J Clin Invest. 1993 Apr;91(4):1327-36.

20.

Expression of tumour necrosis factor (TNF) ligand superfamily co-stimulatory molecules CD30L, CD27L, OX40L, and 4-1BBL in murine hearts with acute myocarditis caused by Coxsackievirus B3.

Seko Y, Takahashi N, Oshima H, Shimozato O, Akiba H, Takeda K, Kobata T, Yagita H, Okumura K, Azuma M, Nagai R.

J Pathol. 2001 Dec;195(5):593-603.

PMID:
11745696
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk